• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Investigating the Role of Sentinel Lymph Node Biopsy in Older Patients with Triple-Negative Breast Cancer.

作者信息

Dalton Juliet C, Record Sydney M, Plichta Jennifer K

机构信息

Department of Surgery, Duke University Medical Center, Durham, NC, USA.

Department of Surgery, Mount Sinai Medical Center, New York, NY, USA.

出版信息

Ann Surg Oncol. 2024 Dec;31(13):8902-8903. doi: 10.1245/s10434-024-16236-2. Epub 2024 Sep 12.

DOI:10.1245/s10434-024-16236-2
PMID:39264550
Abstract
摘要

相似文献

1
ASO Author Reflections: Investigating the Role of Sentinel Lymph Node Biopsy in Older Patients with Triple-Negative Breast Cancer.美国骨科学会作者反思：探究前哨淋巴结活检在老年三阴性乳腺癌患者中的作用
Ann Surg Oncol. 2024 Dec;31(13):8902-8903. doi: 10.1245/s10434-024-16236-2. Epub 2024 Sep 12.
2
ASO Author Reflections: Sequence of Treatment in Clinically Node-Negative T1 Triple-Negative Breast Cancer.ASO作者反思：临床淋巴结阴性T1三阴性乳腺癌的治疗顺序
Ann Surg Oncol. 2023 Dec;30(13):8455-8456. doi: 10.1245/s10434-023-14122-x. Epub 2023 Aug 11.
3
ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.ASO作者反思：基于微小RNA的列线图预测雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌前哨淋巴结转移，以期可能省略前哨淋巴结活检
Ann Surg Oncol. 2020 Dec;27(Suppl 3):810-811. doi: 10.1245/s10434-020-08797-9. Epub 2020 Jul 6.
4
ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.《美国外科医师学会（ASO）作者反思：乳腺癌手术中前哨淋巴结阳性》
Ann Surg Oncol. 2022 Feb;29(2):1096-1097. doi: 10.1245/s10434-021-10836-y. Epub 2021 Sep 24.
5
ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.ASO作者反思：完善仅适合前哨淋巴结活检的淋巴结阳性乳腺癌患者的风险评估
Ann Surg Oncol. 2020 Oct;27(10):3593-3594. doi: 10.1245/s10434-020-08634-z. Epub 2020 May 21.
6
ASO Author Reflections: Considerations in the Debate on Sentinel Node Biopsy in Older Patients with ER+/Her2- Breast Cancer.ASO作者反思：老年ER+/Her2-乳腺癌患者前哨淋巴结活检辩论中的考量因素
Ann Surg Oncol. 2024 May;31(5):3198-3199. doi: 10.1245/s10434-024-15095-1. Epub 2024 Feb 21.
7
ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.ASO作者反思：临床淋巴结阴性患者新辅助化疗后前哨淋巴结切除在切除三个淋巴结后可停止。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):848-849. doi: 10.1245/s10434-020-08874-z. Epub 2020 Jul 21.
8
ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.ASO作者反思：新辅助化疗病理反应后仅接受前哨淋巴结活检的临床淋巴结阳性乳腺癌患者腋窝复发率低
Ann Surg Oncol. 2021 May;28(5):2630-2631. doi: 10.1245/s10434-020-09259-y. Epub 2020 Oct 29.
9
ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?ASO作者反思：新辅助化疗后对淋巴结阳性乳腺癌进行前哨淋巴结手术：从肿瘤学角度看是否安全？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):707-708. doi: 10.1245/s10434-020-08954-0. Epub 2020 Jul 31.
10
ASO Author Reflections: Non-radioactive Sentinel Node Localization with Superparamagnetic Iron Oxide in Clinically Node-Negative Breast Cancer Patients: A Possibility for Improvement of the Care Pathway.ASO作者反思：超顺磁性氧化铁用于临床腋窝淋巴结阴性乳腺癌患者的非放射性前哨淋巴结定位：改善治疗路径的可能性
Ann Surg Oncol. 2021 Jun;28(6):3241-3242. doi: 10.1245/s10434-020-09325-5. Epub 2020 Nov 10.

引用本文的文献

1
Letter to the Editors: Concerning "Nodal Surgery for Patients ≥ 70 Undergoing Mastectomy for DCIS? Choose Wisely" by Elissa C. Dalton et al.致编辑的信：关于伊莉莎·C·道尔顿等人的《70岁及以上接受保乳手术治疗导管原位癌患者的淋巴结手术？明智选择》
Ann Surg Oncol. 2024 Dec;31(13):8931-8932. doi: 10.1245/s10434-024-16061-7. Epub 2024 Aug 21.

本文引用的文献

1
Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With Breast Cancer?解剖学与生物学：哪些因素指导老年乳腺癌患者的化疗决策？
J Surg Res. 2024 Apr;296:654-664. doi: 10.1016/j.jss.2024.01.037. Epub 2024 Feb 14.
2
Triple-negative breast cancer in the elderly: Prognosis and treatment.老年三阴性乳腺癌：预后与治疗
Breast J. 2017 Nov;23(6):630-637. doi: 10.1111/tbj.12813. Epub 2017 May 9.
3
Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States.雌激素受体状态与美国浸润性和原位乳腺癌的未来负担
J Natl Cancer Inst. 2015 Jun 10;107(9). doi: 10.1093/jnci/djv159. Print 2015 Sep.
4
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.早期乳腺癌且年龄 70 岁及以上的女性行保乳手术加他莫昔芬与或不加放疗：CALGB 9343 的长期随访结果
J Clin Oncol. 2013 Jul 1;31(19):2382-7. doi: 10.1200/JCO.2012.45.2615. Epub 2013 May 20.